Prevalence of tissue transglutaminase antibodies and IgA deficiency are not increased in juvenile idiopathic arthritis: a case-control study.

Autor: Kohli AT; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. Angela.Taneja@emory.edu.; Children's Healthcare of Atlanta, Atlanta, GA, USA. Angela.Taneja@emory.edu., Hersh AO; Department of Pediatrics, Spencer F. Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA., Ponder L; Children's Healthcare of Atlanta, Atlanta, GA, USA., Chan LHK; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA., Rouster-Stevens KA; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Children's Healthcare of Atlanta, Atlanta, GA, USA., Tebo AE; University of Utah, Salt Lake City, UT, USA.; ARUP Laboratories, Salt Lake City, USA., Kugathasan S; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Children's Healthcare of Atlanta, Atlanta, GA, USA., Guthery SL; Department of Pediatrics, Spencer F. Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA., Bohnsack JF; Department of Pediatrics, Spencer F. Eccles School of Medicine, University of Utah, Salt Lake City, UT, USA., Prahalad S; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.; Children's Healthcare of Atlanta, Atlanta, GA, USA.
Jazyk: angličtina
Zdroj: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2023 Oct 05; Vol. 21 (1), pp. 110. Date of Electronic Publication: 2023 Oct 05.
DOI: 10.1186/s12969-023-00890-z
Abstrakt: Background: The prevalence of Celiac Disease (CD) in Juvenile Idiopathic Arthritis (JIA) has been reported to be 0.1-7% in various small studies. As a result of the limited number of research and their inconclusive results there are no clear recommendations for routine CD screening in asymptomatic patients with JIA. Our aim is to estimate the prevalence of IgA deficiency and tissue transglutaminase (tTG) IgA in a cohort of JIA followed in two large academic medical centers.
Methods: Serum was collected and stored from all subjects and analyzed in a reference laboratory for total IgA (Quantitative Nephelometry) and tTG IgA antibody levels (Semi-Quantitative Enzyme-Linked Immunosorbent Assay). Fisher's exact tests were performed for statistical significance. Risk estimates (odds ratios) with 95% confidence intervals were calculated.
Results: 808 JIA cases and 140 controls were analyzed. Majority were non-Hispanic whites (72% vs. 68% p = 0.309). A total of 1.2% of cases were IgA deficient compared to none of the controls (p = 0.373). After excluding IgA deficient subjects, 2% of cases had tTG IgA ≥ 4u/mL compared to 3.6% of controls (p = 0.216) (OR = 0.5; 95% C.I = 0.1-1.4); and 0.8% of cases had tTG IgA > 10u/mL compared to 1.4% of controls (p = 0.627) (OR = 0.5; 95%C.I = 0.1-2.9).
Conclusions: Using the largest JIA cohort to date to investigate prevalence of celiac antibodies, the prevalence of positive tTG IgA was 0.8% and of IgA deficiency was 1.2%. The results did not demonstrate a higher prevalence of abnormal tTG IgA in JIA. The study did not support the routine screening of asymptomatic JIA patients for CD.
(© 2023. BioMed Central Ltd., part of Springer Nature.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje